Marc Bonaca Selected Research

Marc Bonaca Research Topics

9	Myocardial Infarction 04/2024 - 01/2019
5	Hemorrhage 11/2023 - 02/2009
4	Venous Thromboembolism 11/2023 - 01/2020
4	Acute Coronary Syndrome 01/2020 - 02/2009
3	COVID-19 11/2023 - 12/2021
2	Thrombosis (Thrombus) 03/2024 - 11/2010
2	Ischemia 11/2023 - 01/2022
2	Ischemic Stroke 11/2023 - 01/2022
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2020
2	Sepsis (Septicemia) 12/2021 - 12/2021
2	Thromboembolism 12/2021 - 12/2021
2	Non-ST Elevated Myocardial Infarction 02/2019 - 02/2009
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2024
1	Hypersensitivity (Allergy) 04/2024
1	Stroke (Strokes) 04/2024
1	Fever (Fevers) 11/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2022
1	Dyslipidemias (Dyslipidemia) 10/2022
1	Peripheral Arterial Disease 01/2022
1	Critical Illness (Critically Ill) 12/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2020
1	Infections 01/2020
1	Pulmonary Embolism 01/2020
1	Genetic Risk Score 01/2020
1	Neoplasms (Cancer) 01/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Aortic Dissection 12/2013
1	Unstable Angina 02/2009
1	ST Elevation Myocardial Infarction 02/2009

3	TicagrelorIBA 01/2022 - 01/2010
2	CSL112IBA 04/2024 - 03/2024
2	CholesterolIBA 04/2024 - 01/2020
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 04/2024 - 03/2024
2	omega-Chloroacetophenone (Mace)IBA 10/2022 - 01/2022
2	SodiumIBA 01/2022 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2020
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2021 - 12/2021
2	fibrin fragment D (D-dimer)IBA 12/2021 - 12/2021
1	HDL LipoproteinsIBA 04/2024
1	Proteins (Proteins, Gene)FDA Link 04/2024
1	RivaroxabanIBA 11/2023
1	AnticoagulantsIBA 11/2022
1	Sunitinib (Sutent)FDA Link 10/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2022
1	avelumabIBA 10/2022
1	Immune Checkpoint InhibitorsIBA 10/2022
1	Axitinib (AG 013736)IBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	Heparin (Liquaemin)FDA LinkGeneric 12/2021
1	Oxygen (Dioxygen)IBA 12/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 10/2021
1	DiureticsIBA 01/2020
1	Proprotein Convertase 9IBA 01/2020
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2020
1	evolocumabIBA 01/2020
1	alirocumabIBA 01/2020
1	dapagliflozinIBA 01/2020
1	Troponin IIBA 05/2010
1	Prasugrel Hydrochloride FDA Link 01/2010
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2010
1	Glycoproteins (Glycoprotein)IBA 02/2009
1	TroponinIBA 02/2009
1	Platelet Membrane Glycoprotein IIbIBA 02/2009

5	Therapeutics 11/2022 - 01/2010
3	Secondary Prevention 08/2019 - 01/2019
1	Stents 03/2024
1	Duration of Therapy 11/2022
1	Surgical Amputation (Amputations) 01/2022
1	Cardiac Rehabilitation 08/2019
1	Endovascular Procedures 12/2013